Note: Ingredients listed on restricted chemical lists
EC/CAS
77-92-9
Name of the chemical
Citric acid
Concentration
0.75 0.35
EC/CAS
532-32-1
Name of the chemical
Benzoic acid and its sodium salt
Concentration
0.25 0.2
General Information
Revision date
2021-06-18
Product name
RETROVIR SYRUP
Product Synonyms
RETROVIR SYRUP 50 MG/5 ML * RETROVIR/AZT ORAL SOLUTION 10 MG/ML * RETROVIR
Emergency telephone
VERISK 3E GLOBAL INCIDENT RESPONSE
Icons in SDS
Company Information
company name
ViiV Healthcare Limited
e-mail address of the competent person responsible for the Safety Data Sheet
msds@gsk.com
GHS Information
Signal word
Warning
Section 2
Physical hazards
Not classified.
Health hazards
Sensitization, skin Category 1 Germ cell mutagenicity Category 2 Carcinogenicity Category 2 Reproductive toxicity Category 2 Specific target organ toxicity, repeated Category 2 exposure
Environmental hazards
Not classified. OSHA defined hazards Not classified.
Signal word
Warning
Hazard statements
May cause an allergic skin reaction. Suspected of causing genetic defects. Suspected of causing cancer. Suspected of damaging fertility or the unborn child. May cause damage to organs through prolonged or repeated exposure.
Prevention
Obtain special instructions before use. Do not handle until all safety precautions have been read and understood. Do not breathe mist/vapors. Contaminated work clothing must not be allowed out of the workplace. Wear protective gloves/protective clothing/eye protection/face protection.
Response
If on skin Wash with plenty of water/. If exposed or concerned Get medical advice/attention Specific treatment (see on this label). If skin irritation or rash occurs: Get medical advice/attention. Wash contaminated clothing before reuse.
Storage
Store locked up.
Disposal
Dispose of contents/container in accordance with local/regional/national/international regulations. Hazard(s) not otherwise Caution - Pharmaceutical agent. See section 11 of the SDS for additional information on health
Classified (HNOC)
hazards.
Additional information
1% of the mixture consists of component(s) of unknown acute dermal toxicity. 64% of the mixture consists of component(s) of unknown acute inhalation toxicity. 11% of the mixture consists of component(s) of unknown acute hazards to the aquatic environment. 11% of the mixture consists of component(s) of unknown long-term hazards to the aquatic environment.
